Directhit

Is Located at Caton Research Center 3918 Vero Road, Suite B Baltimore, MD

DirectHit® Test Panel for Breast Cancer helps physicians predict which anticancer therapy treatments will be the most effective for individual breast cancer patients. Clinical trial results show that DirectHit® predicts, with a high degree of accuracy, the tumor’s resistance and sensitivity to four commonly prescribed classes of breast cancer treatments.